Source link : https://www.newshealth.biz/health-news/osimertinib-plus-sabr-appears-safe-effective-for-advanced-egfr-mutant-nsclc/
In this exclusive MedPage Today video, Erminia Massarelli, MD, PhD, co-director of the lung cancer and thoracic oncology program at City of Hope in Duarte, California, discusses the results and implications of a phase II study evaluating osimertinib (Tagrisso) and consolidative stereotactic ablative radiation (SABR) for the treatment of advanced EGFR-mutant non-small cell lung cancer […]
Author : News Health
Publish date : 2024-06-14 13:00:00
Copyright for syndicated content belongs to the linked Source.
Categories